Hyperlipoproteinemia Type Iii: Disease Bioinformatics
Research of Hyperlipoproteinemia Type Iii has been linked to Hyperlipoproteinemias, Hyperlipidemia, Hypercholesterolemia, Atherosclerosis, Hyperlipoproteinemia Type Iib. The study of Hyperlipoproteinemia Type Iii has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Hyperlipoproteinemia Type Iii include Pathogenesis, Transport, Secretion, Endocytosis, Cholesterol Esterification. These pathways complement our catalog of research reagents for the study of Hyperlipoproteinemia Type Iii including antibodies and ELISA kits against VLDL, APOLIPOPROTEIN B, ALDH9A1, APOA1, APOB.
Hyperlipoproteinemia Type Iii Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Hyperlipoproteinemia Type Iii below!
For more information on how to use Laverne, please read the How to Guide.
We have 768 products for the study of Hyperlipoproteinemia Type Iii that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Hyperlipoproteinemia Type Iii is also known as hyperlipoproteinemia type iii, familial hypercholesterolaemia with hyperlipaemia, familial type 3 hyperlipoproteinemia (disorder), carbohydrate induced hyperlipemia, hypercholesterolemia, familial, remnant hyperlipidemia, hyperlipoproteinemias.